A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma

Journal of Biological Chemistry

Volumn 287, Issue 30, 2012, Pages 25395-25406

  Hayashi, Hideki ^a   Eguchi, Yuko ^a   Fukuchi Nakaishi, Yuko ^a   Takeya, Motohiro ^b   Nakagata, Naomi ^a   Tanaka, Kohichi ^c   Vance, Jean E ^d   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEINS; ASPARTATES; CLINICAL APPLICATION; GLYCOGEN SYNTHASE KINASE-3; INHIBITORY EFFECT; INTRA OCULAR PRESSURE; INTRACELLULAR CA; LOW DENSITY LIPOPROTEINS; MACROGLOBULIN; N METHYL D ASPARTATE RECEPTOR; NEUROPROTECTION; NEUROPROTECTIVE EFFECTS; NEUROTOXICITY; OPTIC NEUROPATHIES; PHOSPHATE-BUFFERED SALINES; RETINAL GANGLION CELLS; THERAPEUTIC STRATEGY;

CELL DEATH; LIPIDS; PROTEINS;

OPHTHALMOLOGY;

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E CONTAINING LIPOPROTEIN; CALCIUM ION; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME INACTIVATION; LOW TENSION GLAUCOMA; MITOCHONDRION; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RETINA GANGLION CELL;

ALPHA-MACROGLOBULINS; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; CALCIUM; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; LOW TENSION GLAUCOMA; MICE; MICE, MUTANT STRAINS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL GANGLION CELLS; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 84864090499     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.370130     Document Type: Article

References (42)

1. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, G. P., and Mariotti, S. P. (2004) Global data on visual impairment in the year 2002. Bull. World Health Organ 82, 844-851 (Pubitemid 39573742)
2. Quigley, H. A. (2011) Glaucoma. Lancet 377, 1367-1377
3. Iwase, A., Suzuki, Y., Araie, M., Yamamoto, T., Abe, H., Shirato, S., Kuwayama, Y., Mishima, H. K., Shimizu, H., Tomita, G., Inoue, Y., and Kitazawa, Y. (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111, 1641-1648 (Pubitemid 39179676)
4. Pekmezci, M., Vo, B., Lim, A. K., Hirabayashi, D. R., Tanaka, G. H., Weinreb, R. N., and Lin, S. C. (2009) The characteristics of glaucoma in Japanese Americans. Arch. Ophthalmol. 127, 167-171
5. Mansberger, S. L., Romero, F. C., Smith, N. H., Johnson, C. A., Cioffi, G. A., Edmunds, B., Choi, D., and Becker, T. M. (2005) Causes of visual impairment and common eye problems in Northwest American Indians and Alaska Natives. Am. J. Public Health 95, 881-886 (Pubitemid 40593754)
6. Shields, M. B. (2008) Normal tension glaucoma: is it different from primary open-angle glaucoma? Curr. Opin. Ophthalmol. 19, 85-88
7. Orgul, S., Zawinka, C., Gugleta, K., and Flammer, J. (2005) Therapeutic strategies for normal tension glaucoma. Ophthalmologica 219, 317-323 (Pubitemid 41628291)
8. Schmidt, K. G., Bergert, H., and Funk, R. H. (2008) Neurodegenerative diseases of the retina and potential for protection and recovery. Curr. Neuropharmacol. 6, 164-178 (Pubitemid 352024799)
9. Bessero, A. C., and Clarke, P. G. (2010) Neuroprotection for optic nerve disorders. Curr. Opin. Neurol. 23, 10-15
10. Ignatius, M. J., Gebicke-Härter, P. J., Skene, J. H., Schilling, J. W., Weisgraber, K. H., Mahley, R. W., and Shooter, E. M. (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. U.S.A. 83, 1125-1129 (Pubitemid 16086425)
11. Petegnief, V., Saura, J., de Gregorio-Rocasolano, N., and Paul, S. M. (2001) Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor κB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E. Neuroscience 104, 223-234 (Pubitemid 32322627)
12. Hayashi, H., Campenot, R. B., Vance, D. E., and Vance, J. E. (2004) Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J. Biol. Chem. 279, 14009-14015 (Pubitemid 38468935)
13. Hayashi, H., Campenot, R. B., Vance, D. E., and Vance, J. E. (2007) Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low density lipoprotein receptor-related protein-1. J. Neurosci. 27, 1933-1941
14. Hayashi, H., Campenot, R. B., Vance, D. E., and Vance, J. E. (2009) Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cγ1 and inhibition of calcineurin. J. Biol. Chem. 284, 29605-29613
15. Harada, T., Harada, C., Nakamura, K., Quah, H. M., Okumura, A., Namekata, K., Saeki, T., Aihara, M., Yoshida, H., Mitani, A., and Tanaka, K. (2007) The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 117, 1763-1770 (Pubitemid 47036310)
16. Mikhailenko, I., Battey, F. D., Migliorini, M., Ruiz, J. F., Argraves, K., Moayeri, M., and Strickland, D. K. (2001) Recognition of α2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions. J. Biol. Chem. 276, 39484-39491
17. Barres, B. A., Silverstein, B. E., Corey, D. P., and Chun, L. L. (1988) Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1, 791-803
18. Bacskai, B. J., Xia, M. Q., Strickland, D. K., Rebeck, G. W., and Hyman, B. T. (2000) The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 11551-11556
19. Henson, M. A., Roberts, A. C., Pérez-Otaño, I., and Philpot, B. D. (2010) Influence of the NR3A subunit on NMDA receptor functions. Prog. Neurobiol. 91, 23-37
20. Campenot, R. B. (1977) Local control of neurite development by nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 74, 4516-4519
21. May, P., Rohlmann, A., Bock, H. H., Zurhove, K., Marth, J. D., Schomburg, E. D., Noebels, J. L., Beffert, U., Sweatt, J. D., Weeber, E. J., and Herz, J. (2004) Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 24, 8872-8883 (Pubitemid 39313893)
22. Lau, A., and Tymianski, M. (2010) Glutamate receptors, neurotoxicity, and neurodegeneration. Pflugers Arch. 460, 525-542
23. Seki, M., and Lipton, S. A. (2008) Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog. Brain Res. 173, 495-510
24. Ullian, E. M., Barkis, W. B., Chen, S., Diamond, J. S., and Barres, B. A. (2004) Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol. Cell. Neurosci. 26, 544-557 (Pubitemid 38969951)
25. Hauser, P. S., Narayanaswami, V., and Ryan, R. O. (2011) Apolipoprotein E: from lipid transport to neurobiology. Prog. Lipid Res. 50, 62-74
26. Hayashi, H. (2011) Lipid metabolism and glial lipoproteins in the central nervous system. Biol. Pharm. Bull 34, 453-461
27. Mahley, R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630
28. Hardingham, G. E. (2009) Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans. 37, 1147-1160
29. Johnson, J. W., and Ascher, P. (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531 (Pubitemid 17056733)
30. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., and Seeburg, P. H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221
31. Wu, H. Y., Tomizawa, K., Oda, Y., Wei, F. Y., Lu, Y. F., Matsushita, M., Li, S. T., Moriwaki, A., and Matsui, H. (2004) Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279, 4929-4940 (Pubitemid 38199089)
32. Hara, M. R., and Snyder, S. H. (2007) Cell signaling and neuronal death. Annu. Rev. Pharmacol. Toxicol. 47, 117-141
33. Almeida, S., Domingues, A., Rodrigues, L., Oliveira, C. R., and Rego, A. C. (2004) FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol. Dis. 17, 435-444 (Pubitemid 39574877)
34. Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E. C., Otto, A., and Pfrieger, F. W. (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357 (Pubitemid 33063104)
35. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981 (Pubitemid 23069980)
36. Krumbiegel, M., Pasutto, F., Mardin, C. Y., Weisschuh, N., Paoli, D., Gramer, E., Weber, B. H., Kruse, F. E., Schlötzer-Schrehardt, U., and Reis, A. (2010) Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J. Glaucoma 19, 561-565
37. Zetterberg, M., Tasa, G., Palmér, M. S., Juronen, E., Teesalu, P., Blennow, K., and Zetterberg, H. (2007) Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma. Am. J. Ophthalmol. 143, 1059-1060 (Pubitemid 46779037)
38. Mabuchi, F., Tang, S., Ando, D., Yamakita, M., Wang, J., Kashiwagi, K., Yamagata, Z., Iijima, H., and Tsukahara, S. (2005) The apolipoprotein E gene polymorphism is associated with open-angle glaucoma in the Japanese population. Mol. Vis. 11, 609-612 (Pubitemid 41410214)
39. Fernández-Monreal, M., López-Atalaya, J. P., Benchenane, K., Léveillé, F., Cacquevel, M., Plawinski, L., MacKenzie, E. T., Bu, G., Buisson, A., and Vivien, D. (2004) Is tissue-type plasminogen activator a neuromodulator? Mol. Cell. Neurosci. 25, 594-601 (Pubitemid 38481470)
40. Qiu, Z., Crutcher, K. A., Hyman, B. T., and Rebeck, G. W. (2003) ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122, 291-303 (Pubitemid 37410161)
41. Rauen, T., Rothstein, J. D., and Wässle, H. (1996) Differential expression of three glutamate transporter subtypes in the rat retina. Cell Tissue Res. 286, 325-336 (Pubitemid 26418041)
42. Bai, Y., Sivori, D., Woo, S. B., Neet, K. E., Lerner, S. F., and Saragovi, H. U. (2011) During glaucoma, α2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection. Invest. Ophthalmol. Vis. Sci. 52, 5260-5265